FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064238076> ?p ?o ?g. }

• W2064238076 endingPage "9" @default.
• W2064238076 startingPage "1" @default.
• W2064238076 abstract "Mitomycin C (MMC) has shown potent efficacy against a wide spectrum of cancers and is clinical first choice in superficial bladder tumors. However, intravesical chemotherapy with MMC has been ineffective due to periodical discharge of the bladder and instability of this drug in acidic pH, both resulting in high rate of tumor recurrence and insufficiency to prevent progression. Nanocarriers may be a promising alternative for prolonged, effective and safe intravesical drug delivery due to their favorable size, surface properties and optimum interaction with mucosal layer of the bladder wall. Hence, the aim of this study was to evaluate and optimize cationic core-shell nanoparticles formulations (based on chitosan (CS) and poly-ϵ-caprolactone (PCL)) in terms of antitumor efficacy after intravesical administration in bladder tumor induced rat model. Antitumor efficacy was determined through the parameters of survival rate and nanoparticle penetration into the bladder tissue. Safety of the formulations were evaluated by histopathological evaluation of bladder tissue as well as observation of animals treated with MMC bound to nanoparticles. Results indicated that chitosan coated poly-ϵ-caprolactone (CS-PCL) nanoparticles presented the longest survival rate among all treatment groups as evaluated by Kaplan–Meier plotting. Histopathological evaluation revealed that cationic nanoparticles were localized and accumulated in the bladder tissue. As intravesical chemotherapy is a local therapy, no MMC was quantified in blood after intravesical instillation indicating no systemic uptake for the drug which could have subsequently led to side effects. In conclusion, core-shell type cationic nanoparticles may be effective tools for the intravesical chemotherapy of recurrent bladder tumors." @default.
• W2064238076 created "2016-06-24" @default.
• W2064238076 creator A5001081360 @default.
• W2064238076 creator A5010866123 @default.
• W2064238076 creator A5025682301 @default.
• W2064238076 creator A5049075240 @default.
• W2064238076 creator A5062058520 @default.
• W2064238076 creator A5076504878 @default.
• W2064238076 date "2014-08-01" @default.
• W2064238076 modified "2023-09-25" @default.
• W2064238076 title "Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy" @default.
• W2064238076 cites W161953857 @default.
• W2064238076 cites W1970829509 @default.
• W2064238076 cites W1971658475 @default.
• W2064238076 cites W1974087189 @default.
• W2064238076 cites W1975646012 @default.
• W2064238076 cites W1979724852 @default.
• W2064238076 cites W1979950437 @default.
• W2064238076 cites W1988034760 @default.
• W2064238076 cites W1989608088 @default.
• W2064238076 cites W1994638195 @default.
• W2064238076 cites W2000219947 @default.
• W2064238076 cites W2001662015 @default.
• W2064238076 cites W2004173569 @default.
• W2064238076 cites W2005071946 @default.
• W2064238076 cites W2010929111 @default.
• W2064238076 cites W2029443189 @default.
• W2064238076 cites W2032087142 @default.
• W2064238076 cites W2034602546 @default.
• W2064238076 cites W2035191786 @default.
• W2064238076 cites W2043157010 @default.
• W2064238076 cites W2046872078 @default.
• W2064238076 cites W2057287977 @default.
• W2064238076 cites W2061784494 @default.
• W2064238076 cites W2068402907 @default.
• W2064238076 cites W2072238622 @default.
• W2064238076 cites W2073504310 @default.
• W2064238076 cites W2082058951 @default.
• W2064238076 cites W2093049579 @default.
• W2064238076 cites W2095372148 @default.
• W2064238076 cites W2098337093 @default.
• W2064238076 cites W2123816487 @default.
• W2064238076 cites W2138934627 @default.
• W2064238076 cites W2155241881 @default.
• W2064238076 cites W2158965678 @default.
• W2064238076 cites W2316712591 @default.
• W2064238076 doi "https://doi.org/10.1016/j.ijpharm.2014.05.014" @default.
• W2064238076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24836669" @default.
• W2064238076 hasPublicationYear "2014" @default.
• W2064238076 type Work @default.
• W2064238076 sameAs 2064238076 @default.
• W2064238076 citedByCount "29" @default.
• W2064238076 countsByYear W20642380762015 @default.
• W2064238076 countsByYear W20642380762016 @default.
• W2064238076 countsByYear W20642380762017 @default.
• W2064238076 countsByYear W20642380762018 @default.
• W2064238076 countsByYear W20642380762019 @default.
• W2064238076 countsByYear W20642380762020 @default.
• W2064238076 countsByYear W20642380762021 @default.
• W2064238076 countsByYear W20642380762023 @default.
• W2064238076 crossrefType "journal-article" @default.
• W2064238076 hasAuthorship W2064238076A5001081360 @default.
• W2064238076 hasAuthorship W2064238076A5010866123 @default.
• W2064238076 hasAuthorship W2064238076A5025682301 @default.
• W2064238076 hasAuthorship W2064238076A5049075240 @default.
• W2064238076 hasAuthorship W2064238076A5062058520 @default.
• W2064238076 hasAuthorship W2064238076A5076504878 @default.
• W2064238076 hasConcept C126894567 @default.
• W2064238076 hasConcept C141071460 @default.
• W2064238076 hasConcept C178790620 @default.
• W2064238076 hasConcept C18150654 @default.
• W2064238076 hasConcept C185592680 @default.
• W2064238076 hasConcept C2776694085 @default.
• W2064238076 hasConcept C2779338040 @default.
• W2064238076 hasConcept C2779732960 @default.
• W2064238076 hasConcept C2779820397 @default.
• W2064238076 hasConcept C2780035454 @default.
• W2064238076 hasConcept C2781303535 @default.
• W2064238076 hasConcept C55493867 @default.
• W2064238076 hasConcept C71924100 @default.
• W2064238076 hasConcept C98274493 @default.
• W2064238076 hasConceptScore W2064238076C126894567 @default.
• W2064238076 hasConceptScore W2064238076C141071460 @default.
• W2064238076 hasConceptScore W2064238076C178790620 @default.
• W2064238076 hasConceptScore W2064238076C18150654 @default.
• W2064238076 hasConceptScore W2064238076C185592680 @default.
• W2064238076 hasConceptScore W2064238076C2776694085 @default.
• W2064238076 hasConceptScore W2064238076C2779338040 @default.
• W2064238076 hasConceptScore W2064238076C2779732960 @default.
• W2064238076 hasConceptScore W2064238076C2779820397 @default.
• W2064238076 hasConceptScore W2064238076C2780035454 @default.
• W2064238076 hasConceptScore W2064238076C2781303535 @default.
• W2064238076 hasConceptScore W2064238076C55493867 @default.
• W2064238076 hasConceptScore W2064238076C71924100 @default.
• W2064238076 hasConceptScore W2064238076C98274493 @default.
• W2064238076 hasFunder F4320322628 @default.
• W2064238076 hasIssue "1-2" @default.
• W2064238076 hasLocation W20642380761 @default.

• next